Article List

WPRIM Management System> DCMS> The Korean Journal of Hepatology> 2009> 15

Volume: 15

1. The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease.	Page:59—69
2. Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients.	Page:52—58
3. The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease.	Page:42—51
4. Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea.	Page:25—41
5. Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection.	Page:7—14
6. Inhibition of hepatitis B virus replication by RNA interference.	Page:1—6
7. Current status of liver disease in Korea: Nonalcoholic fatty liver disease.	Page:S34—S39
8. Clevudine therapy in patients with chronic hepatitis B.	Page:119—121
9. Pathology of nonalcoholic steatohepatitis.	Page:122—130
10. Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation.	Page:131—139
11. Distribution of hepatitis B virus genotypes in Korea.	Page:140—147
12. Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma.	Page:148—158
13. Clinical features of hepatic tuberculosis in biopsy-proven cases.	Page:159—167
14. Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B.	Page:168—178
15. Long-term clevudine therapy in nucleos(t)ide-naive and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases.	Page:179—192
16. A case of hypervascular hyperplastic nodules mimicking hepatocellular carcinoma in alcoholic liver cirrhosis.	Page:193—200
17. A case of liver metastasis of gastric hepatoid adenocarcinoma.	Page:201—208
18. A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy.	Page:90—95
19. Current status of liver diseases in Korea: Toxic and alcoholic liver diseases.	Page:S29—S33
20. Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis.	Page:350—356
21. A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization.	Page:357—361
22. Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx.	Page:15—24
23. Current status of liver diseases in Korea: Liver cirrhosis.	Page:S40—S49
24. Current status of liver diseases in Korea: Hepatocellular carcinoma.	Page:S50—S59
25. Current status of liver diseases in Korea: Hepatocellular carcinoma.	Page:S50—S59
26. Current status of hepatic surgery in Korea.	Page:S60—S64
27. Current status of hepatic surgery in Korea.	Page:S60—S64
28. Current status of liver diseases in Korea: Liver cirrhosis.	Page:S40—S49
29. Current status of liver disease in Korea: Nonalcoholic fatty liver disease.	Page:S34—S39
30. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.	Page:209—215
31. Primary angiosarcoma of the liver.	Page:216—221
32. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.	Page:106—110
33. Angiosarcoma.	Page:101—105
34. Well differentiated hepatocellular carcinoma: ddmPathological diagnosis of needle biopsied liver tissue.	Page:96—100
35. A case of rhabdomyolysis during hospitalization for acute hepatitis A.	Page:85—89
36. A case of hepatocellular carcinoma invading the gallbladder misdiagnosed as a primary gallbladder carcinoma.	Page:80—84
37. Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C.	Page:70—79
38. Current status of liver disease in Korea: Hepatitis C.	Page:S25—S28
39. Current status of liver diseases in Korea: Hepatitis B.	Page:S13—S24
40. Current status of liver diseases in Korea: Hepatitis A.	Page:S7—S12
41. Role of cadherin-17 in hepatocellular carcinoma.	Page:533—535
42. Neuroendocrine tumors of the liver.	Page:528—532
43. Intrahepatic cholangiocarcinoma associated with Clonorchis sinensis infection.	Page:524—527
44. A case of acute cholestatic hepatitis induced by Corydalis speciosa Max.	Page:517—523
45. A case of primary hepatic epithelioid hemangioendothelioma with spontaneous rupture.	Page:510—516
46. Two cases of toxic hepatitis caused by arrowroot juice.	Page:504—509
47. A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C.	Page:496—503
48. Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB.	Page:486—495
49. Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm.	Page:474—485
50. Factors associated with liver stiffness in chronic liver disease.	Page:464—473
51. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease.	Page:454—463
52. Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients.	Page:446—453
53. Epidemiology and clinical features of acute hepatitis A: from the domestic perspective.	Page:438—445
54. Transient elastography, true or false?.	Page:431—437
55. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma.	Page:227—230
56. Epithelioid hemangioendothelioma.	Page:222—226
57. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.	Page:320—330
58. Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in Korean patients with Wilson's disease.	Page:309—319
59. Molecular targeting for treatment of advanced hepatocellular carcinoma.	Page:299—308
60. Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease.	Page:295—298
61. Corrections: Distribution of hepatitis B virus genotypes in Korea.	Page:424—424
62. Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients.	Page:383—390
63. Peliosis hepatis.	Page:379—382
64. Large liver cell change/dysplasia in hepatitis B virus-related liver cirrhosis.	Page:375—378
65. A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C.	Page:370—374
66. Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation.	Page:362—369
67. Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.	Page:338—349
68. Efficacy of 48-week clevudine therapy for chronic hepatitis B.	Page:331—337